Telehealth company LifeMD bought assets from Optimal Human Health MD to accelerate its push into the women’s health market. | ...

It was ghastly to consider that every vial of anti-tetanus serum or life-saving ... methotrexate, Onco-BCG and beyond. I commend the special inter-ministerial committees now monitoring stock ...

The complete response (CR) rate to the combination of the interleukin (IL)-15 superagonist nogapendekin alfa inbakicept-pmln (Anktiva®) and bacillus Calmette-Guerin (BCG) in BCG-unresponsive ...

The probability of being event-free at 36 months was 82.1% (95% CI, 77.4-85.9) with sasanlimab in combination with BCG (induction and maintenance), and 74.8% (95% CI, 69.7-79.2) with BCG alone ...

BCG wants AI to 'increase the joy' in work Related stories In 2023, the firm unveiled ChatGPT Enterprise to all its employees under the stipulation that all data would remain under its control.

Smaller, boutique consulting firms are leveraging AI to compete with established players. Many of these firms have a narrow focus, like helping clients with pricing or cost-cutting. Their methods ...

Pfizer Inc. announced results from the pivotal phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care (SOC) Bacillus ...

According to BCG's "Recovery to Reinvention," more than 70% of the industry's $58 billion growth in revenue in 2024 was driven by market performance rather than by investor inflows, underscoring ...

The immunization took place in some healthcare facilities across the three senatorial districts, where pregnant women and ...

We expect continued democratisation of the market, higher growth of passives and alternatives, and structural movement towards retirement pools,” said Mayank Jha, MD & Partner, BCG. The report ...

The overall safety profile of sasanlimab in combination with BCG was generally consistent with the known profile of BCG and data reported from clinical trials with sasanlimab. The profile of ...

The results demonstrated the longest duration of complete response and highest rate of cystectomy avoidance among therapies studied in BCG-unresponsive NMIBC, including both CIS with or without ...